TELUM THERAPEUTICS
Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
TELUM THERAPEUTICS
Social Links:
Industry:
Biotechnology
Founded:
2019-01-01
Address:
Pamplona, Navarra, Spain
Country:
Spain
Total Employee:
1+
Status:
Active
Total Funding:
4.1 M EUR
Current Advisors List
Current Employees Featured
Founder
Investors List
Clave Mayor
Clave Mayor investment in Seed Round - Telum Therapeutics
Centre for the Development of Industrial Technology (CDTI)
Centre for the Development of Industrial Technology (CDTI) investment in Seed Round - Telum Therapeutics
Invivo Capital Partners
Invivo Capital Partners investment in Seed Round - Telum Therapeutics
More informations about "Telum Therapeutics"
About Us - Telum Therapeutics
Telum Therapeutics SL is a globaldrug discovery biotechnology company specializing in the use of Innovative Phage Lytic Proteins as antibiotics (Innobiotics).See details»
Telum Therapeutics - Crunchbase Company Profile & Funding
Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.See details»
Telum Therapeutics raises € 4.1 million in its first round of …
Dec 17, 2021 Pamplona, Barcelona, 13 th July 2020 – Telum Therapeutics (‘Telum’), an emerging biotechnology company that develops new treatments for infectious diseases based …See details»
Telum Therapeutics - LinkedIn
Telum Therapeutics | 1,456 followers on LinkedIn. The science of today is the technology of tomorrow | Telum Therapeutics SL is a global drug discovery biotechnology company specializing in the ...See details»
Telum Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Telum Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Telum Therapeutics - VentureRadar
Private Company "Telum Therapeutics SL is a global drug discovery biotechnology company specializing in the use of Engineered Phage Lytic Proteins as new antimicrobial products. …See details»
Telum Therapeutics - Funding, Financials, Valuation & Investors
Telum Therapeutics is funded by 3 investors. Clave Mayor and Centre for the Development of Industrial Technology (CDTI) are the most recent investors.See details»
Telum Therapeutics appoints Subhendu Basu as CEO
Mar 19, 2024 Dr. Basu comes to Telum with an impressive tenure of over two decades in bio pharma leadership, with a focus in immunology and infectious diseases where he has gained …See details»
Subhendu Basu Ph.D. - Telum Therapeutics | LinkedIn
I am thrilled to receive the 5 Years of Service Anniversary Award and a congratulation letter from our CEO Marc Casper this week. It has been a… Liked by Subhendu Basu Ph.D.See details»
Overview - Telum Therapeutics
Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. Our technology is based on the extraction of bacterial strains from unexplored …See details»
Seed Round - Telum Therapeutics - 2020-07-13 - Crunchbase
Jul 13, 2020 Invivo Capital — Telum Therapeutics raises € 4.1 million in its first round of financing to advance the development of new synthetic biology-based therapies for the …See details»
Telum Therapeutics appoints Dr. Subhendu Basu as CEO - Yahoo …
Mar 19, 2024 Telum Therapeutics ('Telum'), a pioneering biotechnology company specializing in the innovation of engineered phage endolysins as novel antibacterial agents to combat …See details»
Telum Therapeutics - VentureRadar
Telum Therapeutics SL is a global drug discovery biotechnology company specializing in the use of Engineered Phage Lytic Proteins as new antimicrobial products. Telum Therapeutics is …See details»
Telum Therapeutics appoints Dr. Subhendu Basu as CEO - PR …
Mar 19, 2024 Dr. Basu's vision for Telum Therapeutics involves ushering in a new development phase for its therapies, with a clear corporate strategy which will include a focus on advancing …See details»
Pipeline - Telum Therapeutics
Within our pipeline we have specific programs to treat serious multidrug-resistantGram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas …See details»
Telum Therapeutics appoints Dr. Subhendu Basu as CEO - ASEBIO
Mar 19, 2024 Telum Therapeutic s, a pioneering biotechnology company in the preclinical stage specializing in the innovation of engineered phage endolysins as novel antibacterial agents to …See details»
Telum Therapeutics names Vincent A. Fischetti chairman of its ...
Feb 21, 2023 Telum Therapeutics, a biotechnology company that develops innovative antimicrobial drugs to treat infectious diseases caused by multidrug-resistant bacteria, has …See details»
News - Telum Therapeutics
Feb 12, 2024 Telum Therapeutics joins the United Nations Global Compact In observance of World Health Day on April 7th, Telum Therapeutics announces its membership in the United …See details»
Engineering a lysin by fusion of antimicrobial ... - Telum Therapeutics
Oct 25, 2022 A. baumannii tops the World Health Organization’s list of priority pathogens for the development of new antibiotics. The pathogen is associated with a wide range of infections, …See details»